Protein kinase Cε, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3

Cancer Research

Volumn 67, Issue 3, 2007, Pages 1385-1394

  Aziz, Moammir H ^a   Manoharan, Herbert T ^a   Verma, Ajit K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; MYC PROTEIN; PROTEIN KINASE C EPSILON; SERINE; STAT3 PROTEIN; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CDC25A GENE; CONTROLLED STUDY; GENE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; SKIN CARCINOMA; SKIN DEFECT; SKIN SENSITIVITY; SKIN SENSITIZATION; SQUAMOUS CELL CARCINOMA; SUNLIGHT; TRANSCRIPTION INITIATION; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; SKIN; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; ULTRAVIOLET RAYS;

EID: 33847019644     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3350     Document Type: Article

References (50)

1. Anonymous. Skin cancer; facts and figures. American Cancer Society; 2003.
2. Goldman GD. Squamous cell cancer: a practical approach. Semin Cutan Med Surg 1998;17:80-95.
3. Mukhtar H, Forbes PD, Ananthaswamy HN. Photocarcinogenesis - models and mechanisms. Photodermatol Photoimmunol Photomed 1999;15:91-5.
4. Wheeler DL, Martin KE, Ness KJ, et al. Protein kinase Cε is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res 2004;64:7756-65.
5. Bachelor MA, Cooper SJ, Sikorski ET, et al. Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol Cancer Res 2005;3:90-9.
6. Chen N, Ma W, Huang C, et al. Translocation of protein kinase Cε and protein kinase Cδ to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem 1999;274:15389-94.
7. Denning MF. Epidermal keratinocytes: regulation of multiple cell phenotypes by multiple protein kinase C isoforms. Int J Biochem Cell Biol 2004;36:1141-6.
8. Reddig PJ, Dreckschmidt NE, Zou J, et al. Transgenic mice overexpressing protein kinase Cε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res 2000;60:595-602.
9. Wheeler DL, Li Y, Verma AK. Protein kinase Cε signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through induction of specific cytokines in a paracrine mechanism. Photochem Photobiol 2005;81:7-16.
10. Chan KS, Carbajal S, Kiguchi K, et al. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 2004;64:2382-9.
11. Kobielak A, Fuchs E. Links between α-catenin, NF-κB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A 2006;103:2322-7.
12. Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 2006;6:107-21.
13. Vinkemeier U. Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol 2004;167:197-201.
14. Clevenger CV. Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 2004;165:1449-60.
15. Huang HF, Murphy TF, Shu P, et al. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells. Mol Cancer 2005;4:2.
16. Alvarez JV, Febbo PG, Ramaswamy S, et al. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res 2005;65:5054-62.
17. Chan KS, Sano S, Kiguchi K, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004;114:720-8.
18. Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43-9.
19. Sano S, Chan KS, Kira M, et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 2005;65:5720-9.
20. Wheeler DL, Ness KJ, Oberley TD, et al. Protein kinase Cε is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-α ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cε transgenic mice. Cancer Res 2003;63:6547-55.
21. Turkson J, Bowman T, Garcia R, et al. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 1998;18:2545-52.
22. Li L, Shaw PE. A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun 2004;322:1005-11.
23. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000;19:2628-37.
24. Wang R, Cherukuri P, Luo J. Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem 2005;280:11528-34.
25. Abe K, Hirai M, Mizuno K, et al. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway. Oncogene 2001;20:3464-74.
26. Xuan YT, Guo Y, Zhu Y, et al. Role of the protein kinase Cε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 2005;112:1971-8.
27. Jain N, Zhang T, Kee WH, et al. Protein kinase Cδ associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 1999;274:24392-400.
28. Varinou L, Ramsauer K, Karaghiosoff M, et al. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-γ-dependent innate immunity. Immunity 2003;19:793-802.
29. Shen Y, Schlessinger K, Zhu X, et al. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 2004;24:407-19.
30. Giraud S, Bienvenu F, Avril S, et al. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem 2002;277:8004-11.
31. Schuringa JJ, Schepers H, Vellenga E, et al. Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 2001;495:71-6.
32. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002;109:1139-42.
33. Calo V, Migliavacca M, Bazan V, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003;197:157-68.
34. Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-62.
35. Aznar S, Valeron PF, del Rincon SV, et al. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell 2001;12:3282-94.
36. Li Y, Wheeler DL, Alters W, et al. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma- independent squamous cell carcinoma phenotype in PKCε overexpressing transgenic mice. Toxicol Pathol 2005;33:684-94.
37. Verma AK, Wheeler DL, Aziz MH, et al. Protein kinase Cε and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Mol Carcinog 2006;45:381-8.
38. Jansen AP, Verwiebe EG, Dreckschmidt NE, et al. Protein kinase Cε transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res 2001;61:808-12.
39. Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev 2001;101:2353-64.
40. Mochly-Rosen D, Kauvar LM. Modulating protein kinase C signal transduction. Adv Pharmacol 1998;44:91-145.
41. Gschwendt M, Leibersperger H, Kittstein W, et al. Protein kinase C zeta and eta in murine epidermis. TPA induces down-regulation of PKC eta but not PKC zeta. FEBS Lett 1992;307:151-5.
42. Kazanietz MG. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog 2000;28:5-11.
43. Mischak H, Goodnight JA, Kolch W, et al. Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993;268:6090-6.
44. Perletti GP, Folini M, Lin HC, et al. Overexpression of protein kinase Cε is oncogenic in rat colonic epithelial cells. Oncogene 1996;12:847-54.
45. Horinaga M, Okita H, Nakashima J, et al. Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology 2005;66:671-5.
46. Pan Q, Bao LW, Kleer CG, et al. Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res 2005;65:8366-71.
47. Burke WM, Jin X, Lin HJ, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001;20:7925-34.
48. Ni Z, Lou W, Leman ES, et al. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 2000;60:1225-8.
49. Fernandes A, Hamburger AW, Gerwin BI. ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells. Int J Cancer 1999;83:564-70.
50. Reddig PJ, Dreckschmidt NE, Ahrens H, et al. Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1999;59:5710-8.